Latest return on equity
Supernus Pharmaceuticals Return on equity
Supernus Pharmaceuticals (SUPN) return on equity with its verified observation…
Direct answer
Supernus Pharmaceuticals's return on equity is -10.49%.
The verified market snapshot reports -10.49%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 1, 2026.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -10.49%
Explore related company data
View Supernus Pharmaceuticals's market capitalizationView Supernus Pharmaceuticals's price-to-book ratioView Supernus Pharmaceuticals's 52-week price rangeView Supernus Pharmaceuticals's revenue growthView Supernus Pharmaceuticals's profit marginView Supernus Pharmaceuticals's debt-to-equity ratioView all Supernus Pharmaceuticals key metricsReturn to Supernus Pharmaceuticals profile